Australia - English - Department of Health (Therapeutic Goods Administration)

besins healthcare australia pty ltd - progesterone, quantity: 200 mg - pessary, shell - excipient ingredients: glycerol; lecithin; titanium dioxide; gelatin; purified water; sunflower oil - luteal phase support ? luteal support of assisted reproductive technology (art) cycles,support during pregnancy ? prevention of preterm birth in women with singleton pregnancy who have a short cervix (midtrimester sonographic cervix less than or equal to 25 mm) and/or a history of spontaneous preterm birth. ? treatment of unexplained threatened miscarriage in women with bleeding in the current pregnancy and a history of at least three or more previous miscarriages. use in women with less than three miscarriages may be warranted in those with reduced chances of future pregnancy such as those undergoing ivf treatment with limited viable egg and/or embryo availability or advanced fertility age. however, the benefit of treatment in clinical trials was limited to women with three or more miscarriages. (see section 5 pharmacological properties; clinical trials; threatened unexplained miscarriage)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - cyromazine - topical solution/suspension - cyromazine triazine active 60.0 g/l - parasiticides

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - cyproheptadine hydrochloride sesquihydrate, quantity: 4.3 mg (equivalent: cyproheptadine hydrochloride, qty 4 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; magnesium stearate; pregelatinised maize starch; lactose monohydrate; maize starch - use as an antiallergic-antipruritic agent and relief of migraine and vascular types of headaches.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - tylosin as tartrate - oral powder, pre-mix - tylosin as tartrate antibiotic active 800.0 g/kg - antibiotic & related - broiler | chickens - chronic respiratory disease

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - cyromazine - topical solution/suspension - cyromazine triazine active 500.0 g/l - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - ivermectin - topical solution/suspension - ivermectin anthelmintic active 16.0 g/l - parasiticides

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; trometamol; calcium chloride dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; calcium chloride dihydrate; trometamol; water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.